European Medical Journal

High-Flow Nasal Oxygen Therapy Shows No Benefit After Surgery

High-flow nasal oxygen therapy showed no benefit after cardiac surgery in a major trial. Learn more about the study.

Vapotherm(R) Announces FDA 510(k) Clearance for the All Patient Circuit(TM), Enabling High Velocity Therapy for Neonatal to Adult Patients

Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient ...
MarketWatch

House of Investments Inc.

House of Investments Inc. Annual cash flow by MarketWatch. View HI net cash flow, operating cash flow, operating expenses and cash dividends.
Heart

Home-based, online-monitored high-intensity interval training improves fitness in patients with tetralogy of Fallot: a randomised controlled trial

Introduction Reduced exercise performance is common in patients with repaired tetralogy of Fallot (rToF) and relates to ...
2 Minute Medicine

High-flow nasal oxygen therapy may not be superior to standard oxygen therapy after cardiac surgery

Routine high-flow nasal oxygen therapy (HFNOT) following extubation did not improve outcomes compared to standard oxygen ...